Summary
GlobalData's clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Nonseminomatous Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Nonseminomatous Testicular Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Pfizer Inc.
Amgen Inc.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Clinical Trials by Sponsor Type 19
Prominent Sponsors 20
Top Companies Participating in Nonseminomatous Testicular Cancer Therapeutics Clinical Trials 21
Prominent Drugs 22
Clinical Trial Profile Snapshots 23
Appendix 32
Abbreviations 32
Definitions 32
Research Methodology 33
Secondary Research 33
About GlobalData 34
Contact Us 34
Disclaimer 34
Source 35
List of Tables
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 5
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 16
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 19
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
List of Figures
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 16
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 19
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
GlobalData Methodology 33
